BFSG LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,699
Closed -$763K 220
2023
Q1
$763K Sell
23,699
-44,094
-65% -$1.42M 0.14% 151
2022
Q4
$1.25M Buy
+67,793
New +$1.25M 0.25% 108